RAPID INNOVATE MODEL Trademark

Trademark Overview

On Monday, November 21, 2022, a trademark application was filed for RAPID INNOVATE MODEL with the United States Patent and Trademark Office. The USPTO has given the RAPID INNOVATE MODEL trademark a serial number of 97685809. The federal status of this trademark filing is REGISTERED as of Tuesday, June 25, 2024. This trademark is owned by Molecular Technologies Laboratories LLC. The RAPID INNOVATE MODEL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of new technology for others in the field of Biotechnology, namely, drug discovery services, pre-clinical trial services, and clinical trial services
rapid innovate model

General Information

Serial Number97685809
Word MarkRAPID INNOVATE MODEL
Filing DateMonday, November 21, 2022
Status700 - REGISTERED
Status DateTuesday, June 25, 2024
Registration Number7424890
Registration DateTuesday, June 25, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements

NOT AVAILABLE"MODEL"
Goods and ServicesDevelopment of new technology for others in the field of Biotechnology, namely, drug discovery services, pre-clinical trial services, and clinical trial services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 12, 2022
Primary Code042
First Use Anywhere DateSaturday, December 31, 2022
First Use In Commerce DateSaturday, December 31, 2022

Trademark Owner History

Party NameMolecular Technologies Laboratories LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGalena, OH 43021
Party NameMolecular Technologies Laboratories LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGalena, OH 43021
Party NameMolecular Technologies Laboratories LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGalena, OH 43021

Trademark Events

Event DateEvent Description
Thursday, November 24, 2022NEW APPLICATION ENTERED
Monday, December 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 2, 2023ASSIGNED TO EXAMINER
Monday, September 11, 2023NON-FINAL ACTION WRITTEN
Monday, September 11, 2023NON-FINAL ACTION E-MAILED
Monday, September 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, October 29, 2023TEAS AMENDMENT OF USE RECEIVED
Monday, October 30, 2023USE AMENDMENT FILED
Monday, October 30, 2023AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, November 1, 2023USE AMENDMENT ACCEPTED
Thursday, November 2, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, December 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 6, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 6, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, March 6, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 6, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, March 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 25, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

model innovate rapid services clinical trial discovery drug namely technology others field biotechnology